ArticleCureus2025
Linear Accelerator-Based Stereotactic Radiosurgery (SRS) for Arteriovenous Malformation (AVM) With Functional Magnetic Resonance Imaging (fMRI) Brain Mapping for Toxic Avoidance.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While the treatment of unruptured arteriovenous malformation of the brain (bAVM) is controversial, active intervention is usually recommended for patients who have had a previous intracerebral hemorrhage. Stereotactic radiosurgery (SRS) is the preferred treatment for bAVM when the patient is unsuitable for surgery or embolization. Currently, linear accelerator-based cranial SRS is gaining popularity, and this case report describes the multidisciplinary approach in treating a military sniper with a 3.2 cm x 3.5 cm x 3.7 cm Spetzler-Martin Grade 3 left high parietal AVM using this technique. Functional MRI (fMRI) with block designs was used to identify the motor and vibrotactile areas of the hand and fingers. The patient underwent CT-simulation with frameless double-shell thermoplastic stereotactic mask immobilization followed by CT angiogram in the same position. After co-registration of CT simulation and MRI images, SRS planning was performed with the Eclipse Treatment Planning System (TPS). Two prescription dose levels of 20 Gy and 14 Gy were used. The dose constraints applied in the TPS were: Maximum dose (Dmax) of 16 Gray to the inner/medial wall and 12 Gray to the outer/lateral wall of the left lateral sinus, and 20 Gray to the motor and sensory regions of the brain. Radiological assessment after 32 months showed complete obliteration of the AVM, and the patient did not have any significant toxicity. He is back to his regular job as an army sniper in the armed forces. With the current technological advent of linear accelerators and the TPS algorithms with inverse planning capacity, highly variable and conformal brain SRS plans can be generated based on an individual patient's disease anatomy. Since bAVM is a benign disease and patients may have a long survival after treatment, it is important to ensure that the toxicity from the intervention is minimized. A multidisciplinary team successfully mapped adjacent brain areas, identified the bAVM target, and executed a complex radiotherapy plan, resulting in good outcomes for a patient with parietal bAVM near the hand grip region and left lateral sinus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.